These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33598084)

  • 61. Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
    Bril F; McPhaul MJ; Kalavalapalli S; Lomonaco R; Barb D; Gray ME; Shiffman D; Rowland CM; Cusi K
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4360-e4371. PubMed ID: 34190318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography.
    Lu YB; Weng YC; Huang YN; Huang HY; Cheng PT; Hsieh HS; Tsai MS
    BMC Pulm Med; 2021 Nov; 21(1):387. PubMed ID: 34856978
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of hepatic steatosis and its relation to liver function tests and lipid profile in patients at medical check-up.
    Briseño-Bass P; Chávez-Pérez R; López-Zendejas M
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(3):290-295. PubMed ID: 30292582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.
    Hydes TJ; Summers N; Brown E; Alam U; Thomaides-Brears H; Wilding JPH; Cuthbertson DJ
    Diabet Med; 2020 Nov; 37(11):1793-1806. PubMed ID: 32619031
    [TBL] [Abstract][Full Text] [Related]  

  • 66. US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score?
    Xavier SA; Monteiro SO; Arieira CM; Castro FD; Magalhães JT; Leite SM; Marinho CM; Cotter JB
    Mol Genet Metab; 2021 Mar; 132(3):204-209. PubMed ID: 33558081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Bril F; Millán L; Kalavalapalli S; McPhaul MJ; Caulfield MP; Martinez-Arranz I; Alonso C; Ortiz Betes P; Mato JM; Cusi K
    Diabetes Obes Metab; 2018 Jul; 20(7):1702-1709. PubMed ID: 29527789
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 69. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
    Lee JH; Jeong SJ
    World J Pediatr; 2017 Jun; 13(3):248-254. PubMed ID: 28101773
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
    Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M;
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES.
    Silva MBBE; Tustumi F; Dantas ACB; Miranda BCJ; Pajecki D; DE-Cleva R; Santo MA; Nahas SC
    Arq Bras Cir Dig; 2022; 34(4):e1626. PubMed ID: 35107488
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.
    Petit JM; Pedro L; Guiu B; Duvillard L; Bouillet B; Jooste V; Habchi M; Crevisy E; Fourmont C; Buffier P; Hillon P; Cercueil JP; Verges B
    Diabet Med; 2015 Dec; 32(12):1648-51. PubMed ID: 25981893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Maev IV; Samsonov AA; Lazebnik LB; Golovanova EV; Pavlov CS; Vovk EI; Ratziu V; Starostin KM
    Adv Ther; 2020 Nov; 37(11):4627-4640. PubMed ID: 32939691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
    Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
    World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus.
    Zhao H; Song X; Li Z; Wang X
    Medicine (Baltimore); 2018 Sep; 97(37):e12356. PubMed ID: 30212992
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.
    Younossi ZM; Felix S; Jeffers T; Younossi E; Nader F; Pham H; Afendy A; Cable R; Racila A; Younoszai Z; Lam BP; Golabi P; Henry L; Stepanova M
    JAMA Netw Open; 2021 Sep; 4(9):e2123923. PubMed ID: 34529067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.